Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
Provided By GlobeNewswire
Last update: Apr 24, 2025
-- Strategic pipeline prioritization with workforce and cost reductions expected to extend the company’s cash runway by one year into H2 2027 --
-- Two robust clinical datasets from CB-010 and CB-011 now expected to be disclosed in H2 2025 --
Read more at globenewswire.com
